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Activation  of cytotoxic  T  lymphocytes  (CTL) ~ in  vitro  in  response  to  antigen 
requires a complex series of interactions among T  cell populations and macrophages. 
The demonstration that soluble factors produced  by the various cell types involved 
can mediate these interactions (1, 2) has facilitated the identification of this pathway 
of T  cell activation. 
Two cytokines, interleukin  1 (IL-1) and interleukin  2  (IL-2), are important in the 
development  of cytotoxic  potential.  In  the  presence  of antigen,  macrophages  are 
induced to produce IL-1  (3).  The IL-1 provides a  signal for a  population of helper/ 
inducer T  cells to synthesize IL-2 (4). The released IL-2 binds to receptors on antigen- 
sensitized  cytotoxic  T  cell  precursors  and  leads  to  the  differentiation  of antigen- 
specific cytotoxic effector cells (5), possibly by stimulating the production of immune 
interferon  (6)  by Lyt-l-23  + T  cells. In the absence of T  helper cells exogenous IL-2 
can directly activate cytotoxic precursors against specific antigenic stimuli (7, 8). 
Much of our recent work has focused on the function of murine T  cell populations 
involved in the response to syngeneic I-region determinants in the autologous mixed 
lymphocyte reaction  (AMLR)  (9,  10).  The responding cells in the AMLR are Lyt- 
1+23 -  T  cells, suggesting that they are in the helper-inducer class (11,  12). In previous 
papers  (9,  13),  we  have  demonstrated  that  T  cell  recognition  in  the  AMLR  can 
activate helper cells that, in the presence of hapten-modified determinants on synge- 
neic, nonstimulatory cells, can induce the generation of H-2-restricted, hapten-specific 
cytotoxic activity. Similar results have also been described  in humans  (14,  15).  The 
studies in the human system also described a  factor obtainable from AMLR cultures 
that facilitated the cytotoxic T  cell response to nonstimulatory (heat-treated)  alloge- 
neic  cells  or  to  2,4,6-trinitophenyl-  (TNP)  modified  autologous  peripheral  blood 
lymphocytes (14,  15).  It was suggested that  this  factor might  be IL-2  (14).  Recent 
reports have demonstrated  the presence of IL-2 in AMLR supernatants  from both 
human (16)  and mouse (17,  18) cultures. This was established by the ability of these 
supernatants to promote the continuation ofa mitogen-activated proliferative response 
* Supported by grant AI-15876 from the U. S. Public Health Service, and the Lupus Foundation of 
Northeast Philadelphia, PA. 
1Abbreviations used in  this paper:  alpha-MM, alpha-methyl-D-mannopyranoside;  AMLR, autologous 
mixed lymphocyte reaction; C, complement; Con A, concanavalin A; CSF, colony-stimulating factor; 
CTL, cytotoxic T  lymphocytes; FCS, fetal calf serum; IL-1, interleukin  1;  IL-2, interleukin 2;  IL-3, 
interleukin 3; LU, lytic units; NA(thy), nylon wool column-nonadherent thymocytes; PHA, phytohemag- 
glutinin; TCGF, T cell growth factor; TNP, 2,4,6-trinitrophenyl. 
J. Exp. MED. © The Rockefeller  University  Press • 0022-1007/82/12/1807/14 $1.00  180 7 
Volume 156  December  1982  1807-1820 1808  HELPER  CELLS  IN  AUTOLOGOUS MIXED  LYMPHOCYTE  REACTIONS 
or  to  maintain  an  IL-2-dependent  cell  line.  In  the  mouse,  Lyt-l+23 -  T  cells  are 
involved in the response  in the AMLR  and  in the production  of IL-2. 
The purpose  of this study  is to explore the role of murine AMLR  culture superna- 
tants  in  the generation  of cytotoxicity to modified self and  to  define the relationship 
of the  factor(s)  present  in  the  supernatants  to  known  cytokines.  Evidence  will  be 
presented  to  show  that  the  factor(s)  we  have  obtained  from  our  AMLR  cultures  is 
distinct  from IL-2 and  IL-1  and  is made  by  Lyt-l÷23 -  T  cells. The  position  and  the 
role of the AMLR  supernatant  factor in the cascade of cellular interactions leading to 
the activation of antigen-specific, H-2-restricted  CTL  will be discussed. 
Materials  and  Methods 
Mice.  BALB/c, C3H,  C57BL/6,  and  DBA/2  mice were  purchased  from  the  Laboratory 
Animal Facility of the Institute for Cancer Research, Philadelphia,  PA. 
Cell Preparation and Culture Medium.  Mice were killed by cervical dislocation,  the spleens or 
thymuses  were asceptically removed, and  single cell suspensions  were prepared  as previously 
described  (19).  T  cells were obtained by recovering nonadherent  cells from twice-nylon wool- 
passed spleen cells (20).  Where indicated, thymus cell suspensions were depleted of nylon wool- 
adherent  cells by the same  procedure.  The  culture  medium  was  RPMI  1640  supplemented 
with 10% heat-inactivated fetal calf serum (FCS; Reheis Chemical Co., Phoenix, AZ), 5 X  10  s 
M  2-mercaptoethanol, 20 mM Hepes buffer,  100 U/ml penicillin, and  100/~g/ml streptomycin. 
Batches of FCS were screened,  and  those  that  produced  the  lowest background  proliferative 
responses were selected. 
AMLR Supernatants.  Cultures of 5  ×  106 T  cells plus 5 X  106 mitomycin-C-treated  (25/zg/ 
10 7 cells for 30 min at 37°C) syngeneic spleen cells (AMLR), T  cells alone, mitomycin-C-treated 
spleen cells alone, or Lyt-l+-enriched T  cells plus mitomycin-C-treated syngeneic spleen cells 
were incubated  in 24-well flat-bottomed culture plates  (3524;  Costar,  Data Packaging,  Cam- 
bridge, MA)  in a  final vol of 2.0  ml at  37°C  in 95%  air,  5% CO2 for 2  or 3  d,  as  indicated. 
Supernatants were recovered, centrifuged at  1,000 g for 10 min, passed through 0.45-p,m filters 
(Millipore Corp., Bedford, MA), and frozen until ready for use. 
T Cell Growth Factor (TCGF) Preparation.  IL-2-containing conditioned medium (TCGF) was 
prepared  from concanavalin A- (Con A) stimulated spleen cells as  previously described  (21). 
When TCGF was used in the cytotoxic assay all cultures contained alpha-methyl-D-mannopy- 
ranoside (alpha-MM;  Sigma Chemical Co., St. Louis, MO) at a  final concentration of 0.05 M. 
Antibody Treatments.  T  cells were depleted  of Lyt-123 ÷ and  Lyt-l-23  + cells using an  anti- 
Lyt-2 hybridoma  (22), clone 53-6.7,  generously given to us by Dr. D. E.  Mosier, Institute  for 
Cancer  Research.  T  cells  at  107/ml  were  treated  with  the  antibody  as  undiluted  culture 
supernatant  according to published methods  (18). 
AMLR  cultures  were  depleted  of T  cells  or  non-T  cells  with  monoclonal  anti-Thy-l.2 
antibody  or monoclonal  anti-Ia  a antibody  as  culture  supernatants  derived from  hybridomas 
3X3 (gift of Dr. J. Sprent, University of Pennsylvania, Philadelphia, PA) and MKD6 (developed 
by P. Marrack and J. Kappler; a  gift of Dr. D. E. Mosier), respectively. AMLR cultures were 
d  7  treated with  1 ml of a  1:10 dilution of anti-Thy-l.2  or undiluted  anti-Ia  per  10  cells for 30 
min at 37°C, washed twice, and treated with guinea pig complement  (C)  for 30 rain at  37°C. 
The antibody-treated  AMLR cultures and control cultures treated only with culture medium 
and complement were layered over a  40% Percoll gradient  (Pharmacia,  Fine Chemicals, Div. 
Pharmacia, Inc., Piscataway, N J) and centrifuged at  1,000 g for 10 min. By this method viable 
cells are pelleted  and  dead  cells remain at  the surface.  The  pelleted cells were washed  three 
times and recultured at the original volume for an additional  2 d, at which time supernatants 
were prepared as described above. 
Assay for Help of Cytotoxic Cell Activation.  Cultures of 4  ×  106 T  cells alone, or with 4  X  106 
mitomycin-C-treated syngeneic spleen cells and 4  ×  106 TNP-modified, mitomycin C-treated 
syngeneic  thymocytes  were  done  in  24-well  flat-bottomed  plates.  The  procedure  for  hapten 
modification has been previously described  (23).  To test  for helper factors, supernatants  from 
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the indicated concentrations in place of the syngeneic spleen cells. The final vol throughout 
was 2.0 ml. 
All cultures were incubated in 95% air, 5% CO2 at 37°C for 5 d. Replicate wells were then 
pooled,  viability determined, and  the  cells  plated  in triplicate in  96-well  round-bottomed 
culture plates (Linbro Chemical Co., Hamden, CT) with  104 ~lCr-labeled target cells at final 
effector/target  ratios  of  20:1,  10:1,  and  5:1  unless otherwise  indicated. The  methods  of 
performing the assay and calculating specific  lysis have been previously described (23). Lytic 
units were calculated by the method of Cerrotini and Brunner (24). Briefly, cytotoxic activity 
was plotted on a semilogarithmic  scale against numbers of effector cells. Linear regression lines 
were drawn from cytotoxic values at  the multiple effector/target ratios. One lytic unit (LU) 
was  defined as  the  number of effector  cells  required to  generate 25%  cytotoxicity. LU  per 
culture were determined by dividing the number of cells in  1 LU into the number of viable 
cells recovered from each culture. 
In  the  experiments in  which  LU  were  reported  against  the  haptenated  targets,  only 
background levels of cytotoxicity were detected against unmodified targets at an effector/target 
ratio of 20:1. 
Assessment of Cytokine Activity.  AMLR and TCGF supernatants were tested for their ability 
to support  the  growth  of an  IL-2-dependent cell line and to  act  as  a  co-stimulator in the 
response of thymocytes to Con A and phytohemagglutin (PHA). The IL-2-dependent cell line 
T22A6 was derived from a C57B1/6 cytotoxic cell clone and was maintained in TCGF. Both 
the cell line and the assay for testing for IL-2 activity were given to us by Dr. H. R. Snodgrass 
(Institute for Cancer Research). To measure IL-2, 2 ×  104 cell  line cells were cultured with 
serial dilutions  of the test supernatants in 96-well flat-bottomed plates (3596; Costar) in a final 
vol of 0.1  ml. After 24  h  at  37°C  individual wells were pulsed for 4  h  with 0.5  ~Ci  [125I]- 
iododeoxyuridine; (New  England Nuclear, Boston, MA). Cultures were harvested onto glass 
fiber filter paper (934 AH; Reeve Angel, Clifton, N  J) with an automated multi-sample  harvester 
(MASH  II; Microbiological Associates,  Walkersville, MD).  Incorporation of radiolabel was 
measured on a  Beckman Biogamma (Beckman Instruments, Inc., Fullerton, CA). The prolif- 
erative response was calculated by subtracting the counts per minute in the cell line cultured 
alone from cultures containing  dilutions of the test supernatant. IL-2 activity was calculated as 
decribed by Farrar et al. (25). The Con A and PHA co-stimulator assays were performed with 
CBA or BALB/c thymocytes, as reported in the literature (8, 26), and units of activity calculated 
according to the method of Farrer et al. (25). In our hands the cell line will detect IL-2; the Con 
A co-stimulator assay primarily measures IL-2, but also detects IL-I to some extent; and the 
PHA  thymocyte assay  detects  IL-2  or  IL-1  equally well  (J.  A.  Wolos  and J.  B.  Smith, 
unpublished observations). 
Results 
Helper Factors Produced in the Murine AMLR Capable of  Mediating a Cytotoxic  Response.  In 
experiments designed to  determine if soluble factors  from  murine AMLR  cultures 
were capable of mediating a cytotoxic response to modified self, as has been shown in 
humans  (14,  15),  BALB/c  AMLR  culture supernatant from  day  3  of culture was 
added into fresh cultures containing BALB/c T  cells and syngeneic TNP-modified, 
mitomycin-C-treated thymocytes.  As  seen  in Table I,  and  in  agreement  with  our 
previous reports (9,  13),  the addition of TNP-modified T  cells to an AMLR resulted 
in  the  recovery  of  substantial cytotoxic  activity  against  TNP-modified  syngeneic 
targets  after  5  d  in culture.  In the  absence of the  splenic stimulators virtually no 
cytotoxicity  developed.  However,  the  addition of AMLR  supernatants into  these 
cultures  resulted  in  the  activation  of CTL  directed  against  hapten-modified self 
targets.  The maximum helper activity was demonstrable with day-3 AMLR  super- 
natant at 25% of the final vol. Kinetic studies reveal that helper factors appear to be 
present in AMLR cultures as early as day 1, with maximum activity obtained by day 
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TABLE  I 
Effect of AMLR Supernatants on the Generation of Cytotoxicity to 
TNP-modified Self* 
BALB/c 
AMLR  Cytotoxic- 
Experi-  Cultures  superna-  ity; TNP- 
ment  tant  (25%  BALB/c 
vol/vol) 
L U/ culture 
BALB/c 
T + spleenm + TNP-thym  --  24.7 
T + TNP-thym  --  0.0 
T + TNP-thym  10%  6.4 
T + TNP-thym  25%  26.8 
T + TNP-thym  50%  21.4 
BALB/c T  +  0 
TNP-thym  +  0 
T + TNP-thym  +  26.3 
* T  cells  (T), mitomycin-C-treated spleen cells  (spleenm),  and TNP-modified, 
mitomycin-C-treated thymocytes (TNP-thym) were all  at  concentrations of 
all  at 4 ×  106/well  in 2.0-ml  vol. 
These  results  do  not  allow  us  to  determine  if both  T  cells  and  TNP-modified 
thymocytes are  necessary for the AMLR  supernatants  to mediate  a  response.  Some 
mitogens, such as Con-A, will polyclonally activate cytotoxic precursor T  cells in the 
absence of the target antigen (27). If the AMLR factor acts as a T  cell mitogen, TNP- 
self-directed  cytotoxicity could  occur in  the  absence  of TNP-modified  thymocytes. 
Alternatively, cytokines such  as  IL-2 have been  demonstrated  to activate cytotoxic 
precursor cells in the thymus in the presence of hapten-altered self (7).  It is possible 
that TNP-modified thymocytes act as both the antigen-presenting cells and the source 
of the cytotoxic effectors. In this study, the addition of day-3 AMLR supernatants to 
purifed  T  cells  at  the  initiation  of culture  resulted  in  no  demonstrable  cytotoxic 
activity (Table I, experiment  2).  Likewise, TNP-modified, mitomycin-C-treated thy- 
mocytes failed to generate TNP-induced self-directed cytotoxic cells when cultured in 
the  presence  of AMLR  supernatants.  Significant  cytotoxic activity  was  detectable 
only in those cultures that contained T  cells, TNP-modified thymocytes, and AMLR 
supernatants. Thus it appears the cytotoxic activity mediated by AMLR supernatants 
requires  an  interaction  between  T  cells  and  TNP-modified,  mitomycin-C-treated 
thymocytes. 
Interacting  Cell Types in the Generation of AMLR Supernatant Helper Factors.  Our initial 
experiments determined that AMLR supernatants contained helper factors that could 
mediate a CTL response. Further work was done to investigate the cellular interactions 
required  for  the  production  of  this  factor.  In  experiment  1  of Table  II,  day-3 
supernatants  from T  cells cultured  alone,  mitomycin-C-treated spleen cells cultured 
alone,  or T  cells  plus  mitomycin-C-treated  spleen  cells  (AMLR)  were  assayed  for 
helper activity. The separate  responder and stimulator  populations  did not produce 
helper factors. Only the AMLR supernatants were active in helping the generation of 
cytotoxicity against TNP-modified self. 
In experiment 2 of Table II, T  cell populations that had been depleted of Lyt-123  + JEFFREY A. WOLOS AND J.  BRUCE SMITH 
TABLE II 





Cultures  Supernatant source  icity; 
(25% vol/vol)  TNP- 
BALB/c 
1  BALB/c T + TNP-thym 
2  BALB/c T + TNP-thym 
L U/culture 
--  0 
T  0 
Spleenm  0.2 
T + spleen, (AMLR)  26.3 
--  0 
T + spleenm (AMLR)  28.4 
Lyt-l+T + spleenm  30.3 
* See footnotes  to Table I. 
and Lyt-1-23  + T  cells by treating with a monoclonal anti-Lyt 2 serum plus C  (Lyt-1  + 
T  cells)  were  incubated  with  mitomycin C-treated  syngeneic spleen  cells  for  3  d. 
Supernatants from these cultures were assayed for helper activity and compared with 
supernatants  from AMLR cultures containing untreated  T  cells.  The cultures con- 
taining Lyt-1  + T cells produced as much or more helper factors than the conventional 
AMLR.  This  implies  a  major  role  for  the  Lyt-I  +  helper/inducer  T  cell  in  the 
production of AMLR helper factors. Cells within The Lyt-1  + T  cell population have 
been reported to be the responder in the AMLR (11,  12). 
Cells  Responsible for the AMLR  Helper Factor.  Data  in  Table II provided evidence 
that a Lyt-1+23  -  T  cell-spleen cell interaction was necessary for the production of the 
AMLR helper factor. It has been mentioned that as early as day 1 of culture, helper 
factors  can  be  detected  in  AMLR  supernatants.  This  suggests  that  the  cellular 
recognition events initiating the production of the factor have taken place by day  1. 
If that is the case, removal of the cell populations not involved in the actual synthesis 
of the factor after day 1 might not affect its production. To test this hypothesis BALB/ 
c AMLR cultures were harvested on day  1 and incubated with a  monoclonal anti- 
Thy-l.2 plus C,  monoclonal anti-Ia  a plus  C,  or culture  medium  plus  C.  After the 
antibody treatment dead cells were removed on a 40% Percoll gradient. This treatment 
resulted  in  substantial  cell  loss  using either  monoclonal antibody.  The  viable cells 
were resuspended  up to the original volume and cultured  for an  additional  2 d, at 
which time supernatants were assayed for helper activity. In Table III it is seen that 
day-3 supernatants from AMLR cultures treated only with medium and C  on day  1 
were strongly active in inducing the generation of TNP-modified self-directed cyto- 
toxicity. Treatment of the AMLR cultures on day 1 with anti-Thy-1.2 plus C resulted 
in the recovery of day-3 supernatants with no significant helper activity. Interestingly, 
removal of Ia-bearing splenic B cells  and macrophages from the AMLR stimulator 
population with anti-Ia  a plus C  on day 1 slightly enhanced the production of helper 
factors  as  measured  by  the  activity  of day-3  supernatants.  These  results  strongly 
suggest that  the AMLR helper  factor is  made by a  T  cell,  and combined with  the 
data in experiment 2 of Table II, suggest that the T cell has the Lyt-1  +23- phenotype. 
Effect  of AMLR  Supernatants  and  TCGF  on  the  Activation  of  Cytotoxic  Precursors  in 
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TABLE III 
Effect of Antibody  Treatment of the AMLR on the Generation of Helper 
Factors* 
Day-3  Cytotox- 
AMLR  Treatment on day 1  icity; 
superna-  TNP- 
tants~:  BALB/C 
L U/well 
BALB/C 
T + TNP-thym  -  --  0.0 
T + TNP-thym  +  C only  21.3 
T + TNP-thym  +  anti-Thy 1.2 + C  0.2 
T + TNP-thym  +  anti-Ia  d + C  39.0 
* See footnotes to Table I. 
:~ 50% vol/vol in culture. 
TABLE IV 
AMLR Factor Is Not IL-2 and Does Not Activate  Thymocytes* 
BALB/c cultures:~  BALB/C  Cytotoxic-ity;  TNP- 
supernatants  BALB/c 
T + TNP-thym 
L U/culture 
--  0 
25% AMLR  16.8 
Thymocytes + TNP-thym  --  0 
10% AMLR  0 
25% AMLR  0 
50% AMLR  0 
T + TNP-thym  25% TCGF  30.5 
Thymocytes + TNP-thym  10% TCGF  6.1 
25% TCGF  16.9 
50% TCGF  24.0 
* See footnotes to Table I. 
~: All cultures have 0.05-M alpha-MM final concentration. 
tion of cytotoxicity in vitro (1, 2). One of these, IL-2, is produced by Lyt-1 + helper/ 
inducer T  ceils and can activate cytotoxic precursors  in thymus, spleen, or  lymph 
node  in  the  presence  of an  antigenic stimulus such  as  allogeneic cells  or  hapten- 
modified self (2, 7, 8). The requirement for mature helper T  ceils is bypassed. Recently 
it has been reported that IL-2 is produced in an AMLR  (17,  18).  If our cultures are 
producing IL-2, we would expect to be able to activate thymocytes in this system. In 
Table IV, the results of adding AMLR supernatants or IL-2-rich, Con A-stimulated 
spleen cell supernatants (TCGF) to cultures containing T  cells or thymocytes as the 
responding cells are shown. All cultures contained 0.05  M  alpha-MM to  bind any 
Con A  in the supernatants. When splenic T  cells were cultured with TNP-modified 
thymocytes, both the AMLR supernatants and the TCGF preparations activated cells 
cytotoxic  for  hapten-modified self targets.  However,  only  the  TCGF  preparation 
induced the maturation of cytotoxic precursors in the thymocyte population. At no JEFFREY A. WOLOS AND J.  BRUCE  SMITH  1813 
IL-2-DEPENDENT  CELL  LINE  COSTIMULATOR  ASSAY  COSTIMULATOR  ASSAY 
CON-A  +  THYMOCYTE5  PHA + THYMOCYTES 
100-  100-  ~  50- 
75-  75-  • 
~  ~  30- 
~_  'o  'o 
x  50-  x  50-  x 
v  20- 
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0  .....  a---B-  --a  I  I  I  I  I  i  0  I  I  I  0  I 
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SUPERNATANT  DILUTION  5UPERNATANT  DILUTION  5UPERNATANT  DILUTION 
FIo.  l.  Function of AMLR supernatants in maintaining an IL-2-dependent cell line or in acting 
as co-stimulator in response to Con A or PHA. Dilutions of AMLR supernatants  (0--0) or IL-2- 
containing TCGF (1~-O)  were titrated into cultures and the proliferative response was measured 
on day 1 (cell line) or day 3 (co-stimulator assay). 
concentration tested did the AMLR supernatants  activate thymocytotoxic precursors 
in the presence of hapten-modified  self. Thus the factor in the AMLR  supernatants 
does not have one of the biological attributes of IL-2: the ability to activate cytotoxic 
precursors from the thymocyte population. 
Support  of an  IL-2-dependent  Cell  Line,  or Activity  in  Co-stimulator Assays,  of AMLR 
Supernatants.  The previous experiments suggest the AMLR factor is distinct from IL- 
2  in that  it  only affects mature T  cells.  To further examine this  possibility,  AMLR 
supernatants  were tested for their ability to support  an IL-2-dependent cell line and 
for their ability to act as a  co-stimulator in the response of thymocytes to Con A  (8) 
or to PHA  (26).  Fig.  1 shows that  the  IL-2-containing TCGF standard  was able to 
maintain a  strong dose-dependent proliferative response by the cell line. The AMLR 
supernatants,  at  all  concentrations tested,  did  not  support  the continued  growth of 
this  line.  Likewise,  although our TCGF  preparation  was  highly active in  both  the 
Con A and PHA co-stimulator assays, AMLR supernatants had insignificant activity. 
These results support the conclusion that the factor or factors present  in the AMLR 
supernatants are not IL-2. 
Another cytokine that activates mature helper T  cells and induces them to produce 
IL-2 is  IL-1. However,  IL-1 is produced  by macrophages  (4),  and we have  demon- 
strated  the factor is synthesized by T  cells.  In addition,  the co-stimulator assays will 
detect  IL-1  to  varying  degrees  (25,  26;  and  J.  A.  Wolos  and  J.  B.  Smith).  The 
inactivity  in  these  assays  provides  further  evidence  that  the  factor  in  the  AMLR 
supernatants  is not IL-1. 
Target ofAMLR Supernatant Factor.  The preceding data demonstrate that the helper 
factor obtained  from the  AMLR  is  synthesized  by Lyt-1 + T  cells,  but  is  not  IL-2. 
Because  T  cells  produce  it,  it  is  also  not  IL-1.  A  population  of T  cells  has  been 
postulated  that interacts with macrophages to induce them to produce IL-1 (28, 29). 
It is possible that the factor we are studying is a T  cell mediator initiating macrophage 
activation. Although it would appear there are no macrophages in our cytotoxic assay 
system, the thymocyte populations have been reported to contain a  small number of 1814  HELPER CELLS  IN AUTOLOGOUS MIXED LYMPttOCYTE REACTIONS 
macrophages and other cells, such as dendritic cells, which are capable of producing 
IL-1  (30,  31).  These cells cannot  present  antigen  to the T  cells  in our system in  the 
absence of exogenous helper  factors,  as evidenced by the consistently poor cytotoxic 
activity  demonstrable  in  cultures  composed  of only  T  cells  and  TNP-modified, 
inactivated  thymocytes. However, it is possible the addition of AMLR  helper factors 
could induce these cells  to make  IL-1  and  thus  initiate  the  process of cytotoxic cell 
activation.  To examine  the  role of non-T cells  in  the  thymocyte population  in  the 
AMLR-factor-mediated induction of cytotoxicity, thymocytes were depleted  of non- 
T  cells by passage over nylon wool columns before TNP modification. The results of 
using these cells in our cytotoxic assay system are presented  in Table V. 
In the absence ofsyngeneic splenic stimulators or AMLR supernatants,  no cytotox- 
icity  developed  regardless  of whether  unselected  or  nonadherent  thymocytes  were 
used as the hapten  carrier.  In agreement  with previous experiments,  the addition  of 
syngeneic  mitomycin-C-treated  spleen  cells  to  the  cultures  of T  cells  plus  hapten- 
modified  thymocytes  resulted  in  the  generation  of substantial  cytotoxic  activity 
against  TNP-modified  self targets.  The  use  of TNP-modified  nylon  wool  column- 
nonadherent  thymocytes  [(NA)thy]  had  no  significant  diminishing  effect  on  the 
generation of cytotoxicity. However, when AMLR  supernatants  were substituted  for 
the splenic stimulators  in this  system a  disparity between  the results obtained  using 
TNP-modified  unselected  thymocytes  or  TNP-modified  (NA)thy  was  observed.  In 
those  cultures  in  which  the  hapten  was  presented  in  the  context  of (NA)thy,  the 
ability of AMLR supernatants  to help in the activation of TNP-modified self-specific 
cytotoxicity was severely depressed  compared with similar cultures  using unselected 
thymocytes.  These  results  suggest  that  the  AMLR  supernatant  mediates  its  effect 
through a  nylon wool-adherent thymocyte. 
Discussion 
Our data  demonstrate  that  supernatants  from murine  AMLR  cultures  contain  a 
helper  factor(s)  that  aids  in  the  development  of hapten-specific  cytotoxicity. It  has 
become clear  that  multiple  factors produced  by  interacting  cell  types  mediate  the 
cytotoxic T  cell response.  IL-2 (32), a  product of activated  Lyt-l+23  -  T  cells  (8),  is 
able  to  amplify  the  cytotoxic response  of spleen  cells  or  thymocytes to  allogeneic 
TABLE V 
Loss of Helper Activity in the Absence of Thymic Adherent Cells* 
BALB/c 
AMLR su-  Cytotoxicity; 




T + spleenm + TNP-thym  -  36.6 
T + TNP-thym  -  0.0 
T + TNP-thym  +  20.5 
T + spleenm + TNP-(NA)thym  -  29.1 
T + TNP-(NA)thym  -  0.0 
T + TNP-(NA)thym  +  0.0 
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tumor cells and supports generation of cytotoxic activity by spleen cells in response to 
nonstimulatory ultraviolet-light-treated allogeneic spleen cells  (2).  IL-2 production 
requires the presence of macrophages (8). These macrophage functions are mediated 
by another cytokine, IL-1  that  can,  like IL-2, be obtained from Con A-stimulated 
spleen cell cultures (29), but is frequently prepared from activated peritoneal exudate 
cells or macrophage tumor lines  (1,  4,  33).  IL-1  can substitute  for macrophages in 
inducing the production of IL-2 (4, 25). 
These are  the  two best-characterized factors in  the pathway of cytotoxic T  cell 
activation, with macrophages producing IL-1, which  in  turn  activates appropriate 
Lyt-1+23  -  T  cells to produce IL-2, which provides a proliferation and/or differentia- 
tion signal to antigen-sensitized cytotoxic T  cell precursors. It is apparent, however, 
that  there are other factors and  cell types involved. Reports in  the literature have 
suggested that immune interferon, produced by Lyt-1-23  + T  cells (34) in response to 
IL-2, assists  in the maturation of CTL (6).  Immune interferon can also be found in 
supernatants from cultures of Con A-stimulated spleen cells (35). 
There is recent evidence that one of the early events in the initiation of the CTL 
response is an interaction between T cells and macrophages resulting in the production 
of IL-1 (29)..The Lyt-1  +23- T  cell involved is distinct from the IL-2-producing T  cell 
and it may function via a soluble mediator, which has been termed interleukin 3 (IL- 
3)  (28). The use of this notation for the factor is not generally accepted, as a number 
of other reports have described active mediators also designated as IL-3, which may 
or may not  be related to the T  cell factor mentioned above  (36-38).  One  better- 
defined mediator, colony-stimulating factor (CSF), may be similar to the macrophage- 
inducing IL-3. It is present, as are all the previously mentioned factors, in supernatants 
from cultures of Con A-stimulated mouse spleen cells (39)  and  is also produced by 
Con A or phorbol myristic acetate stimulation of a  thymoma cell line, suggesting T 
cell origin (40, 41). CSF has been demonstrated to activate macrophages to produce 
IL-1 (42) and therefore may be crucial in the differentiation of cytotoxic precursors. 
The autologous  mixed  lymphocyte reaction  (AMLR)  measures  the  proliferative 
response of T  cells to autologous or syngeneic I  region determinants  (9,  10)  and  is 
detectable in both mouse (43) and human (44) systems. Helper cells or uncharacterized 
factors in human AMLR cultures have been shown to promote a  CTL response to 
non-stimulatory (heat-treated) allogeneic cells or to TNP-modified autologous periph- 
eral blood lymphocytes (14,  15). In addition, helper factors have been obtained from 
the human AMLR that induced fresh peripheral blood mononuclear cells to produce 
antibody either in the presence or absence of antigen (15, 45). 
We have previously described a  method  for using helper T  cells activated  in  a 
murine AMLR to mediate a cytotoxic response to hapten-modified self (9, 13). In the 
present study, a factor present in AMLR cultures mediated an interaction between T 
cells and TNP-modified inactivated syngeneic thymocytes in the absence of syngeneic 
stimulator cells, resulting in the generation of hapten-specific cytotoxic effectors. The 
production of the helper factor was dependent on an interaction between T  cells and 
mitomycin-C-treated spleen cells. Depleting Lyt-123  + and  Lyt-l-23  + T  cells before 
culture in  the AMLR  had  no effect on  the production of helper factor. Although 
these data do not determine whether the factor is being made by Lyt-1+23  -  T  cells or 
by cells in the stimulator population, it proves that  Lyt-123  ÷ and Lyt-l-23  ÷ T  cells 
are not necessary for its production. 1816  HELPER CELLS IN AUTOLOGOUS MIXED LYMPHOCYTE REACTIONS 
The identity of the cell type responsible for producing the AMLR helper factor was 
clarified because as early as day  1, helper activity can be detected in AMLR culture 
supernatants,  indicating  the  recognition  events necessary for factor production  had 
taken place by day 1. The depletion of T  or non-T cells in the AMLR on day 1 using 
monoclonal  antibodies, with  subsequent  recuhure  until  day 3,  revealed  that  active 
supernatants  were recoverable only from the non-T-depleted cultures  (T cells).  It is 
interesting to note that  the depletion of the Iaa-bearing stimulator cells after  1 d  of 
culture did not adversely affect the production of the helper factor. It is possible that 
the  anti-Ia  a  treatment  did  not  remove  all  the  h-positive  cells,  although  similar 
dilutions  of antibody have abolished  the proliferative response in both AMLR and 
mixed lymphocyte cultures  (J. A. Wolos and J. B. Smith, unpublished observations). 
Regardless  of whether  the  stimulating  cells  were  totally  removed,  the  presence  of 
helper factors in AMLR cultures treated with anti-Ia  a and the total absence of helper 
activity in those cultures treated with anti-Thy-l.2 strongly suggest that the AMLR 
helper factor is produced by a  T  cell. These data, combined with  the evidence that 
active factors were recovered from AMLR cultures with Lyt-1+23  .  responder T  ceils, 
provide strong evidence that the AMLR factor is produced by a  Lyt-l÷23  -  T  cell. 
The similar biological acivities of our AMLR factor and IL-2 preparations in the 
activation of splenic cytotoxic cells, as well as the dependence on the presence of Lyt- 
1+23 .  T  cells for the production  of both factors, suggested our AMLR helper factor 
might be IL-2. Indeed, culture supernatants recovered from the AMLR in mice (17, 
18)  and humans  (16)  have been reported to contain  factors with properties of IL-2. 
Unlike  the  results  reported  for IL-2  (27,  28),  when  our  AMLR  supernatants  were 
added  to  cultures  of thymocytes  plus  TNP-modified,  inactivated  thymocytes,  no 
cytotoxicity  developed  despite  the  ability  of these  same  supernatants  to  activate 
splenic T  cells in response to TNP-modified, inactivated thymocytes. IL-2-containing 
TCGF  from Con  A-stimulated spleen  cells was  able to  help  both  thymocytes and 
mature T  cells in the generation of hapten-specific cytotoxicity. The inactivity of the 
AMLR supernatants when cultured with immature T  cells suggests the factor is not 
IL-2. Our  AMLR  helper  factors is  probably different  from the  non-IL-2 mediator 
recoverable from a  secondary AMLR  (46),  as those  supernatants  will  also activate 
thymocyte precursors for cytotoxic cells. Further support for the conclusion that our 
AMLR factor is distinct from IL-2 comes from the failure of the AMLR supernatants 
to support an IL-2-dependent cell line, or to function effectively as a co-stinmlator in 
the thymocyte response to Con A or PHA. 
As  distinct  from those  studies  that  detect  IL-2  in  the  AMLR  (17,  18),  we  used 
different mouse strains, culture conditions, cell populations, and length of culture (3 
d  instead of 5  d).  By  duplicating  the conditions reported  for obtaining IL-2 in  the 
murine AMLR (17,  18),  low levels of IL-2 were rarely detectable in AMLR cultures 
(Dr.  M.  H.  Bocchieri, personal communication). Regardless of whether IL-2 can be 
obtained in the AMLR under certain conditions, the results of our biological assays 
demonstrate we are dealing with an active mediator distinct from IL-2. 
The production of the AMLR factor by a T  cell rules out the possibility that  it is 
IL-I. In addition, the PHA co-stimulator assay has been reported to detect IL-1 (26), 
and in our hands the Con A  thymocyte assay will also detect IL-1. The inactivity of 
our supernatants in these assays provides further evidence that our factor is not IL-1. 
As  we  cannot  directly  activate cytotoxic  precursors  in  the  thymus,  the  AMLR JEFFREY  A.  WOLOS AND J.  BRUCE SMITH  1817 
factor  may activate  mature  T  helper  cells,  inducing  the  production  of IL-2,  and 
mediating  the  generation  of cytotoxic activity.  Indeed,  some  IL-2  is  detectable  in 
supernatants from assay cultures incubated in the presence of the AMLR factor (J. A. 
Wolos and B. A. Smith, unpublished observations). Our assay system is composed of 
only T  cells and  thymocytes. Therefore, the  initial  interpretation  was that  we had 
bypassed the  macrophage  (and  IL-1)  requirement  in  the  generation  of CTL.  The 
thymocyte population,  however, contains  a  small percentage of nonlymphoid cells, 
primarily macrophages and dendritic  cells,  that  have the ability to present antigen 
(30).  The thymic macrophages, when properly stimulated, can produce IL-1  (31).  In 
our  studies,  when  thymic  adherent  cells  were  removed  by nylon  column  passage, 
haptenated thymocytes were still able to induce the generation of substantial cytotox- 
icity when added into AMLR cultures.  However, the AMLR helper factor could no 
longer facilitate the induction  of cytotoxic T  cells if the thymocytes had been passed 
over nylon wool columns before hapten modification. Thus, it appears that a thymic 
adherent cell is a necessary intermediate in our system. 
We therefore propose that in our system, a factor(s) derived from Lyt-1+23  -  T  cells, 
and present in AMLR supernatants, activates thymic macrophages to produce IL-1. 
In the  presence of IL-1  and  hapten-modified  self,  helper T  cells  are stimulated  to 
synthesize  IL-2,  which  induces  the  differentiation  of cytotoxic  effector  cells  from 
antigen-sensitized cytotoxic precursors, probably in the presence of immune interferon 
and other, as yet uncharacterized,  factors. This suggested role for the AMLR factor 
in the cascade of events leading to T  cell activation is consistent with current models 
of cytotoxic cell differentiation. 
The characterization of the factor, and its relationship to the different putative IL- 
3 and to CSF is being examined. Experiments are also underway that will determine 
the  relationships  between  the  T  cell  producing  the  AMLR  factor,  the  AMLR- 
proliferating T  cell, and the IL-2-producing T  cell. 
Summary 
In normal mice, the autologous mixed lymphocyte reaction  (AMLR)  can activate 
helper T  cells that, in the presence of hapten-modified syngeneic cells, can induce a 
hapten-specific  cytotoxic  response.  Supernatants  from  AMLR  cultures  contain  a 
factor(s)  that  will  mediate  a  cytotoxic T  cell  response  to  hapten-altered  self.  The 
AMLR factor is effective in  facilitating the generation  of cytotoxicity only in  those 
cultures containing both T  cells and hapten-altered, syngeneic, nonstimulatory cells. 
Factor production  requires  an  interaction  between  Lyt-l+23  -  cells and  non-T cells 
(the T  cells synthesize it). The AMLR factor does not appear to be interleukin 2 (IL- 
2)  because it  does not  activate thymocytes in  the  presence of antigen,  nor  does  it 
maintain  an  IL-2-dependent  cell  line  or  function  in  co-stimulator assays.  For  the 
AMLR factor to facilitate the generation of cytotoxicity, thymic adherent cells are a 
necessary intermediate. These data suggest that the factor recoverable from AMLR 
cultures acts early in the cytotoxic pathway, before IL-1 production. 
Received  for publication 22June 1982 and in revised  form 13 August  1982. 
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